Related Experiment Videos

Mouse mammary tumor virus: a virus that exploits the immune system

D Bramblett1, J Liu, M Lozano

  • 1Dept. of Microbiology, University of Pennsylvania Medical School, Philadelphia 19104, USA.

Leukemia
|April 1, 1997
PubMed

Insights

Mouse mammary tumor virus (MMTV) strains that cause T-cell tumors lack a specific binding site for NBP (negative regulatory element binding protein). This absence likely increases MMTV transcription and mutagenic integration in T-cells.

Area of Science:

  • Virology
  • Oncology
  • Immunology

Background:

  • Mouse mammary tumor virus (MMTV) is associated with mammary carcinomas and T-cell tumors in mice.
  • MMTV strains inducing T-cell tumors exhibit distinct genetic alterations, specifically large deletions in the U3 region of the long terminal repeat (LTR).

Purpose of the Study:

  • To investigate the molecular mechanisms underlying the tropism of MMTV variants towards T-cell tumors.
  • To identify specific genetic differences in T-cell tropic MMTV strains that contribute to their oncogenic potential.

Main Methods:

  • Comparative analysis of MMTV LTR sequences from mammary tumor-inducing and T-cell tumor-inducing strains.
  • Investigation of cellular protein binding sites within the MMTV LTR, focusing on NBP (negative regulatory element binding protein).

Main Results:

  • T-cell tropic MMTV strains possess a large deletion in the U3 region of the LTR compared to mammary tumor strains.
  • Evidence suggests that T-cell tropic MMTV strains lack a critical binding site for the cellular protein NBP.
  • The absence of NBP binding sites correlates with higher MMTV transcription levels in T-cells.

Conclusions:

  • The lack of NBP binding sites in T-cell tropic MMTV is a key factor in their oncogenicity.
  • This molecular alteration likely enhances MMTV transcription and promotes mutagenic integration events within T-cells, leading to tumor development.

Related Concept Videos